S&P Global Inc (NYSE: SPGI) has reported earnings for its third fiscal quarter (ending September 30) of $2.34 versus $1.84 for the same period a year ago — an increase of 27%. However, this result […]
ImmunoGen Inc (NASDAQ: IMGN) has reported E.P.S. of $0.10 for its third fiscal quarter (ending September 30) versus $-0.31 for the same period a year ago. Relative to the consensus estimate of $0.04, this was […]
Molson Coors Beverage Company (NYSE: TAP) has reported E.P.S. of $1.99 for its third fiscal quarter (ending September 30) versus $1.00 for the same period a year ago — an increase of 99%. This result […]
The AES Corp (NYSE: AES) has reported E.P.S. of $0.34 for its third fiscal quarter (ending September 30) versus $0.63 for the same period a year ago — a decline of -46%. Relative to the […]
For its third fiscal quarter (ending September 30), Baxter International Inc (NYSE: BAX) has reported E.P.S. of $0.09 compared to $-5.94 a year ago. This result fell short of the consensus estimate of $0.69 by […]
Fortinet Inc (NASDAQ: FTNT) has reported earnings for its third fiscal quarter (ending September 30) of $0.41 versus $0.29 for the same period a year ago — an increase of 41%. This result exceeded the […]
For its third fiscal quarter (ending September 30), Celldex Therapeutics Inc (NASDAQ: CLDX) has reported E.P.S. of $-0.81 compared to $-0.57 a year ago. This performance was $-0.15 short of the consensus estimate of $-0.66. […]
Navios Maritime Partners LP (NYSE: NMM) has reported earnings for its third fiscal quarter (ending September 30) of $2.92 versus $8.36 for the same period a year ago — a decline of -65%. Relative to […]
For its third fiscal quarter (ending September 30), ICF International Inc (NASDAQ: ICFI) has reported a 25% increase in E.P.S. from $1.01 a year ago to $1.26 in the current quarter. However, this result fell […]
PGT Innovations Inc (NYSE: PGTI) has reported E.P.S. of $0.68 for its third fiscal quarter (ending September 30) versus $0.51 for the same period a year ago — an increase of 33%. Relative to the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research